You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationExciting News from Tiefenbacher Group!
We are thrilled to announce the grand inauguration of our newly constructed development and production facilities in Hyderabad, India! This marks a significant milestone in our mission to develop and manufacture high-quality, affordable pharmaceuticals for patients worldwide.
Our new facilities
Our state-of-the-art complex spans 4,000 m², featuring cutting-edge laboratories and production facilities designed to meet the highest safety and GxP compliance standards. The new facilities provide product development labs, analytical labs, administrative offices, and an employee canteen. A key highlight is our new oncology drug production unit, enabling us to expand our specialty pharmaceuticals portfolio. With over 20 leading highly potent oncology drugs in our launch pipeline, this investment strengthens our role as an innovation leader in the industry. Additionally, we held a groundbreaking ceremony for the expansion of the Production Block 1 which is used for other pharmaceuticals indications.
Festive inauguration ceremony
This memorable event was graced by our esteemed managing directors, Tiefenbacher family shareholders, and advisory board members. To mark this special occasion, we hosted a festive inauguration ceremony at our Hyderabad site, bringing together our employees, leadership team, and distinguished guests. The celebration featured inspiring speeches by our leadership team, including Swapnil Singh, Sandip Tarate, Oliver Schrader & Dr. Kristian Ruepp, as well as honored dignitaries, recognition of our dedicated project team, a vibrant cultural show, a live band performance, and a delightful dinner.
Tiefenbacher Group’s commitment
This expansion and celebration underscore Tiefenbacher Group’s commitment to innovation and excellence as a fully integrated global pharmaceutical company. Our Hyderabad site continues to set industry benchmarks with its advanced technologies, stringent quality standards, and dedication to improving global healthcare. A big thank you to our incredible team and partners who made this possible!
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
